Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
Health centers must report all cases of hepatitis C to federal officials, but a study suggests that all but one case of hepatitis C went unreported in Massachusetts in a ... Read more
A study of over 3,000 eligible subjects in the Electronically Retrieved Cohort of Hepatitis C Viral (HCV) Infected Veterans (ERCHIVES) identified that statin use may be beneficial to sustained virologic ... Read more
With a long liver transplant wait list for patients with hepatocellular carcinoma due to hepatitis B virus, clinicians are keen to find alternative methods of treating their patients. For some ... Read more
Despite the hope generated by more efficacious, safer hepatitis C drugs within the past years, a number of patients with the chronic liver disease may not qualify for access to ... Read more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more